Alan A. Azambuja
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
- Orthopedics and Sports Medicine top 10%
- Bone and Joint Diseases
Papers in
- Oncology 10
- Bone health and treatments 6
- Cancer Diagnosis and Treatment 3
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 2
-
- Oral health in cancer treatment 2
- Co-authors
- Karen Cherubini (6 shared papers)Fernanda Gonçalves Salum (4 shared papers)Maria M. Campos (1 shared paper)Fernanda Bueno Morrone (5 shared papers)Luci Bavaresco (1 shared paper)Ana Maria Oliveira Battastini (2 shared papers)Michaël Wink (1 shared paper)Elizandra Braganhol (1 shared paper)
In The Last Decade
Alan A. Azambuja
15 papers receiving 213 citations
Peers
Comparison fields: 5 of 59
- Physiology 55
- Orthopedics and Sports Medicine 84
- Oncology 128
- Rheumatology 38
- Pharmacy 9
Countries citing papers authored by Alan A. Azambuja
This map shows the geographic impact of Alan A. Azambuja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan A. Azambuja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan A. Azambuja more than expected).
Fields of papers citing papers by Alan A. Azambuja
This network shows the impact of papers produced by Alan A. Azambuja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan A. Azambuja. The network helps show where Alan A. Azambuja may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan A. Azambuja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 68 | |
| 2 | 2009 | 68 | |
| 3 | 2012 | 22 | |
| 4 | 2010 | 19 | |
| 5 | 2006 | 13 | |
| 6 | 2016 | 12 | |
| 7 | INCREASED 5’NUCLEOTIDASE ACTIVITY IN THE BLOOD SERUM OF BRAIN TUMOR PATIENTS | 2016 | 3 |
| 8 | Effect of temozolomide treatment on the adenine nucleotide hydrolysis in blood serum of rats with implanted gliomas | 2009 | 3 |
| 9 | 2020 | 3 | |
| 10 | Toxicity of capecitabine compared with 5-fluorouracil in elderly patients with breast or gastrointestinal tract cancer | 2011 | 2 |
| 11 | 2021 | 2 | |
| 12 | 2014 | 2 | |
| 13 | Bisphosphonates and jaw osteonecrosis | 2009 | 1 |
| 14 | 2008 | 1 | |
| 15 | 2022 | 1 |
About Alan A. Azambuja
Alan A. Azambuja is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Orthopedics and Sports Medicine, Physiology and Surgery, having authored 15 papers that have together received 220 indexed citations. Recurring topics across this work include Bone health and treatments (6 papers), Bone and Joint Diseases (4 papers), Adenosine and Purinergic Signaling (3 papers), Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Testicular diseases and treatments (2 papers) and Oral health in cancer treatment (2 papers). The work is most often cited by research in Physiology (55 citations), Orthopedics and Sports Medicine (84 citations), Oncology (128 citations), Rheumatology (38 citations) and Pharmacy (9 citations). Alan A. Azambuja has collaborated with scholars based in Brazil and France. Frequent co-authors include Karen Cherubini, Fernanda Gonçalves Salum, Maria M. Campos, Fernanda Bueno Morrone, Luci Bavaresco, Ana Maria Oliveira Battastini, Michaël Wink, Elizandra Braganhol, Liliana Rockenbach and Carlos H. Barrios. Their work appears in journals such as Journal of Oral Pathology and Medicine, Oral Diseases, Clinical Oral Investigations, Journal of Clinical Oncology and Head & Neck.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.